nile Antibody
nile Antibody
West Nile Virus Antibody |
|||
GWB-376E67 | GenWay Biotech | 0.1 mg | Ask for price |
West Nile Virus Antibody |
|||
GWB-4D0204 | GenWay Biotech | 0.1 mg | Ask for price |
West Nile Virus Antibody |
|||
GWB-B704DB | GenWay Biotech | 0.1 mg | Ask for price |
West Nile Virus Antibody |
|||
GWB-E45DB2 | GenWay Biotech | 0.1 mg | Ask for price |
West Nile Virus (WNV) Antibody |
|||
abx412023-01mg | Abbexa | 0.1 mg | 610.8 EUR |
West Nile Virus (WNV) Antibody |
|||
abx412023-100g | Abbexa | 100 µg | 537.5 EUR |
West Nile Virus Core Antibody |
|||
24281 | SAB | 100ul | 479 EUR |
West Nile Virus Core Antibody |
|||
24281-100ul | SAB | 100ul | 468 EUR |
West Nile Virus Core Antibody |
|||
3435-002mg | ProSci | 0.02 mg | 206.18 EUR |
Description: West Nile Virus Core Antibody: West Nile Virus (WNV) is a member of the Flaviviridae, a plus-stranded virus family that includes St. Louis encephalitis virus, yellow fever virus, and Dengue virus. WNV was initially isolated in 1937 in the West Nile region of Uganda and has become prevalent in Africa, Asia, and Europe. It has rapidly spread across the United States with cases being observed in every continental state. Virus particles consist of a dense core made up of the core/capsid protein encapsulating the RNA genome surrounded by a membrane envelope embedded with envelope and matrix proteins which play a major role for WNV entry into target cells. The viral core protein is thought to contribute to the WNV-associated inflammation via apoptosis induced though the caspase-9 pathway as delivery of core gene delivery into the striatum of mouse brain and skeletal muscle resulted in cell death and inflammation. |
|||
West Nile Virus Core Antibody |
|||
3435-01mg | ProSci | 0.1 mg | 523.7 EUR |
Description: West Nile Virus Core Antibody: West Nile Virus (WNV) is a member of the Flaviviridae, a plus-stranded virus family that includes St. Louis encephalitis virus, yellow fever virus, and Dengue virus. WNV was initially isolated in 1937 in the West Nile region of Uganda and has become prevalent in Africa, Asia, and Europe. It has rapidly spread across the United States with cases being observed in every continental state. Virus particles consist of a dense core made up of the core/capsid protein encapsulating the RNA genome surrounded by a membrane envelope embedded with envelope and matrix proteins which play a major role for WNV entry into target cells. The viral core protein is thought to contribute to the WNV-associated inflammation via apoptosis induced though the caspase-9 pathway as delivery of core gene delivery into the striatum of mouse brain and skeletal muscle resulted in cell death and inflammation. |
|||
West Nile Virus Matrix Antibody |
|||
24278 | SAB | 100ul | 479 EUR |
West Nile Virus Matrix Antibody |
|||
24278-100ul | SAB | 100ul | 468 EUR |
West Nile Virus Matrix Antibody |
|||
24279 | SAB | 100ul | 479 EUR |
West Nile Virus Matrix Antibody |
|||
24279-100ul | SAB | 100ul | 468 EUR |
West Nile Virus Matrix Antibody |
|||
3429-002mg | ProSci | 0.02 mg | 206.18 EUR |
Description: West Nile Virus Matrix Antibody: West Nile Virus (WNV) is a member of the Flaviviridae, a plus-stranded virus family that includes St. Louis encephalitis virus, yellow fever virus, and Dengue virus. WNV was initially isolated in 1937 in the West Nile region of Uganda and has become prevalent in Africa, Asia, and Europe. It has rapidly spread across the United States with cases being observed in every continental state. Virus particles consist of a dense core made up of the core/capsid protein encapsulating the RNA genome surrounded by a membrane envelope embedded with envelope and matrix proteins. However, when the viruses are inside of infected cells, the matrix protein exists in its "pre-M" form as a heterodimer with the envelope proteins. Cleavage of the "pre-M" protein to its mature form occurs during release of the virus; this cleavage leas to the dissociation of the heterodimers. The WNV receptor has recently been identified as alpha v beta 3 integrin. |
|||
West Nile Virus Matrix Antibody |
|||
3429-01mg | ProSci | 0.1 mg | 523.7 EUR |
Description: West Nile Virus Matrix Antibody: West Nile Virus (WNV) is a member of the Flaviviridae, a plus-stranded virus family that includes St. Louis encephalitis virus, yellow fever virus, and Dengue virus. WNV was initially isolated in 1937 in the West Nile region of Uganda and has become prevalent in Africa, Asia, and Europe. It has rapidly spread across the United States with cases being observed in every continental state. Virus particles consist of a dense core made up of the core/capsid protein encapsulating the RNA genome surrounded by a membrane envelope embedded with envelope and matrix proteins. However, when the viruses are inside of infected cells, the matrix protein exists in its "pre-M" form as a heterodimer with the envelope proteins. Cleavage of the "pre-M" protein to its mature form occurs during release of the virus; this cleavage leas to the dissociation of the heterodimers. The WNV receptor has recently been identified as alpha v beta 3 integrin. |
|||
West Nile Virus Matrix Antibody |
|||
3431-002mg | ProSci | 0.02 mg | 206.18 EUR |
Description: West Nile Virus Matrix Antibody: West Nile Virus (WNV) is a member of the Flaviviridae, a plus-stranded virus family that includes St. Louis encephalitis virus, yellow fever virus, and Dengue virus. WNV was initially isolated in 1937 in the West Nile region of Uganda and has become prevalent in Africa, Asia, and Europe. It has rapidly spread across the United States with cases being observed in every continental state. Virus particles consist of a dense core made up of the core/capsid protein encapsulating the RNA genome surrounded by a membrane envelope embedded with envelope and matrix proteins. However, when the viruses are inside of infected cells, the matrix protein exists in its "pre-M" form as a heterodimer with the envelope proteins. Cleavage of the "pre-M" protein to its mature form occurs during release of the virus; this cleavage leas to the dissociation of the heterodimers. The WNV receptor has recently been identified as alpha v beta 3 integrin. |
|||
West Nile Virus Matrix Antibody |
|||
3431-01mg | ProSci | 0.1 mg | 523.7 EUR |
Description: West Nile Virus Matrix Antibody: West Nile Virus (WNV) is a member of the Flaviviridae, a plus-stranded virus family that includes St. Louis encephalitis virus, yellow fever virus, and Dengue virus. WNV was initially isolated in 1937 in the West Nile region of Uganda and has become prevalent in Africa, Asia, and Europe. It has rapidly spread across the United States with cases being observed in every continental state. Virus particles consist of a dense core made up of the core/capsid protein encapsulating the RNA genome surrounded by a membrane envelope embedded with envelope and matrix proteins. However, when the viruses are inside of infected cells, the matrix protein exists in its "pre-M" form as a heterodimer with the envelope proteins. Cleavage of the "pre-M" protein to its mature form occurs during release of the virus; this cleavage leas to the dissociation of the heterodimers. The WNV receptor has recently been identified as alpha v beta 3 integrin. |
|||
West Nile Virus Envelope Antibody |
|||
24282 | SAB | 100ul | 479 EUR |
West Nile Virus Envelope Antibody |
|||
24282-100ul | SAB | 100ul | 468 EUR |
West Nile Virus Envelope Antibody |
|||
24283 | SAB | 100ul | 479 EUR |
West Nile Virus Envelope Antibody |
|||
24283-100ul | SAB | 100ul | 468 EUR |
West Nile Virus Envelope Antibody |
|||
24284 | SAB | 100ul | 479 EUR |
West Nile Virus Envelope Antibody |
|||
24284-100ul | SAB | 100ul | 468 EUR |
West Nile Virus Envelope Antibody |
|||
3437-002mg | ProSci | 0.02 mg | 206.18 EUR |
Description: West Nile Virus Envelope Antibody: West Nile Virus (WNV) is a member of the Flaviviridae, a plus-stranded virus family that includes St. Louis encephalitis virus, yellow fever virus, and Dengue virus. WNV was initially isolated in 1937 in the West Nile region of Uganda and has become prevalent in Africa, Asia, and Europe. It has rapidly spread across the United States with cases being observed in every continental state. Virus particles consist of a dense core made up of the core/capsid protein encapsulating the RNA genome surrounded by a membrane envelope embedded with envelope and matrix proteins. While the viral core protein is thought to contribute to the WNV-associated inflammation via apoptosis induced though the caspase-9 pathway, the highly glycosylated envelope protein plays a major role for WNV entry into target cells as this entry can be inhibited by using a recombinant domain III from the envelope glycoprotein. The WNV receptor has recently been identified as alpha v beta 3 integrin. |
|||
West Nile Virus Envelope Antibody |
|||
3437-01mg | ProSci | 0.1 mg | 523.7 EUR |
Description: West Nile Virus Envelope Antibody: West Nile Virus (WNV) is a member of the Flaviviridae, a plus-stranded virus family that includes St. Louis encephalitis virus, yellow fever virus, and Dengue virus. WNV was initially isolated in 1937 in the West Nile region of Uganda and has become prevalent in Africa, Asia, and Europe. It has rapidly spread across the United States with cases being observed in every continental state. Virus particles consist of a dense core made up of the core/capsid protein encapsulating the RNA genome surrounded by a membrane envelope embedded with envelope and matrix proteins. While the viral core protein is thought to contribute to the WNV-associated inflammation via apoptosis induced though the caspase-9 pathway, the highly glycosylated envelope protein plays a major role for WNV entry into target cells as this entry can be inhibited by using a recombinant domain III from the envelope glycoprotein. The WNV receptor has recently been identified as alpha v beta 3 integrin. |
|||
West Nile Virus Envelope Antibody |
|||
3439-002mg | ProSci | 0.02 mg | 206.18 EUR |
Description: West Nile Virus Envelope Antibody: West Nile Virus (WNV) is a member of the Flaviviridae, a plus-stranded virus family that includes St. Louis encephalitis virus, yellow fever virus, and Dengue virus. WNV was initially isolated in 1937 in the West Nile region of Uganda and has become prevalent in Africa, Asia, and Europe. It has rapidly spread across the United States with cases being observed in every continental state. Virus particles consist of a dense core made up of the core/capsid protein encapsulating the RNA genome surrounded by a membrane envelope embedded with envelope and matrix proteins. While the viral core protein is thought to contribute to the WNV-associated inflammation via apoptosis induced though the caspase-9 pathway, the highly glycosylated envelope protein plays a major role for WNV entry into target cells as this entry can be inhibited by using a recombinant domain III from the envelope glycoprotein. The WNV receptor has recently been identified as alpha v beta 3 integrin. |
|||
West Nile Virus Envelope Antibody |
|||
3439-01mg | ProSci | 0.1 mg | 523.7 EUR |
Description: West Nile Virus Envelope Antibody: West Nile Virus (WNV) is a member of the Flaviviridae, a plus-stranded virus family that includes St. Louis encephalitis virus, yellow fever virus, and Dengue virus. WNV was initially isolated in 1937 in the West Nile region of Uganda and has become prevalent in Africa, Asia, and Europe. It has rapidly spread across the United States with cases being observed in every continental state. Virus particles consist of a dense core made up of the core/capsid protein encapsulating the RNA genome surrounded by a membrane envelope embedded with envelope and matrix proteins. While the viral core protein is thought to contribute to the WNV-associated inflammation via apoptosis induced though the caspase-9 pathway, the highly glycosylated envelope protein plays a major role for WNV entry into target cells as this entry can be inhibited by using a recombinant domain III from the envelope glycoprotein. The WNV receptor has recently been identified as alpha v beta 3 integrin. |
|||
West Nile Virus Envelope Antibody |
|||
3441-002mg | ProSci | 0.02 mg | 206.18 EUR |
Description: West Nile Virus Envelope Antibody: West Nile Virus (WNV) is a member of the Flaviviridae, a plus-stranded virus family that includes St. Louis encephalitis virus, yellow fever virus, and Dengue virus. WNV was initially isolated in 1937 in the West Nile region of Uganda and has become prevalent in Africa, Asia, and Europe. It has rapidly spread across the United States with cases being observed in every continental state. Virus particles consist of a dense core made up of the core/capsid protein encapsulating the RNA genome surrounded by a membrane envelope embedded with envelope and matrix proteins. While the viral core protein is thought to contribute to the WNV-associated inflammation via apoptosis induced though the caspase-9 pathway, the highly glycosylated envelope protein plays a major role for WNV entry into target cells as this entry can be inhibited by using a recombinant domain III from the envelope glycoprotein. The WNV receptor has recently been identified as alpha v beta 3 integrin. |
|||
West Nile Virus Envelope Antibody |
|||
3441-01mg | ProSci | 0.1 mg | 523.7 EUR |
Description: West Nile Virus Envelope Antibody: West Nile Virus (WNV) is a member of the Flaviviridae, a plus-stranded virus family that includes St. Louis encephalitis virus, yellow fever virus, and Dengue virus. WNV was initially isolated in 1937 in the West Nile region of Uganda and has become prevalent in Africa, Asia, and Europe. It has rapidly spread across the United States with cases being observed in every continental state. Virus particles consist of a dense core made up of the core/capsid protein encapsulating the RNA genome surrounded by a membrane envelope embedded with envelope and matrix proteins. While the viral core protein is thought to contribute to the WNV-associated inflammation via apoptosis induced though the caspase-9 pathway, the highly glycosylated envelope protein plays a major role for WNV entry into target cells as this entry can be inhibited by using a recombinant domain III from the envelope glycoprotein. The WNV receptor has recently been identified as alpha v beta 3 integrin. |
|||
West Nile Virus Core Protein Antibody |
|||
abx023202-100ug | Abbexa | 100 ug | 811.2 EUR |
Polyclonal West Nile Virus Core Antibody |
|||
AMM05447G | Leading Biology | 0.1 mg | 790.8 EUR |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human West Nile Virus Core . This antibody is tested and proven to work in the following applications: |
|||
OAMA02321-1MG - West Nile Virus Antibody |
|||
OAMA02321-1MG | Aviva Systems Biology | 1mg | 899 EUR |
OAMA02438-1MG - West Nile Virus Antibody |
|||
OAMA02438-1MG | Aviva Systems Biology | 1mg | 899 EUR |
OAMA02469-1MG - West Nile Virus Antibody |
|||
OAMA02469-1MG | Aviva Systems Biology | 1mg | 899 EUR |
OAMA02481-1MG - West Nile Virus Antibody |
|||
OAMA02481-1MG | Aviva Systems Biology | 1mg | 949 EUR |
West Nile Virus Envelope Protein Antibody |
|||
abx022312-1mg | Abbexa | 1 mg | 1296 EUR |
West Nile Virus Envelope Protein Antibody |
|||
abx022314-1mg | Abbexa | 1 mg | 1228.8 EUR |
West Nile Virus Envelope Protein Antibody |
|||
abx022315-1mg | Abbexa | 1 mg | 1296 EUR |
West Nile Virus Envelope Protein Antibody |
|||
abx022316-1mg | Abbexa | 1 mg | 1296 EUR |
West Nile Virus Envelope Protein Antibody |
|||
abx022312-400l | Abbexa | 400 µl | Ask for price |
West Nile Virus Envelope Protein Antibody |
|||
abx022312-80l | Abbexa | 80 µl | 1250 EUR |
West Nile Virus Envelope Protein Antibody |
|||
abx022314-400l | Abbexa | 400 µl | Ask for price |
West Nile Virus Envelope Protein Antibody |
|||
abx022314-80l | Abbexa | 80 µl | 1362.5 EUR |
West Nile Virus Envelope Protein Antibody |
|||
abx022315-400l | Abbexa | 400 µl | Ask for price |
West Nile Virus Envelope Protein Antibody |
|||
abx022315-80l | Abbexa | 80 µl | 1250 EUR |
West Nile Virus Envelope Protein Antibody |
|||
abx022316-400l | Abbexa | 400 µl | Ask for price |
West Nile Virus Envelope Protein Antibody |
|||
abx022316-80l | Abbexa | 80 µl | 1250 EUR |
Polyclonal West Nile Virus Matrix Antibody |
|||
AMM05450G | Leading Biology | 0.1 mg | 790.8 EUR |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human West Nile Virus Matrix . This antibody is tested and proven to work in the following applications: |
|||
Polyclonal West Nile Virus Matrix Antibody |
|||
APR11227G | Leading Biology | 0.1 mg | 790.8 EUR |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human West Nile Virus Matrix . This antibody is tested and proven to work in the following applications: |
|||
Polyclonal West Nile Virus Envelope Antibody |
|||
AMM05448G | Leading Biology | 0.1 mg | 790.8 EUR |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human West Nile Virus Envelope . This antibody is tested and proven to work in the following applications: |
|||
Polyclonal West Nile Virus Envelope Antibody |
|||
AMM05449G | Leading Biology | 0.1 mg | 790.8 EUR |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human West Nile Virus Envelope . This antibody is tested and proven to work in the following applications: |
|||
Polyclonal West Nile Virus Envelope Antibody |
|||
APR11226G | Leading Biology | 0.1 mg | 790.8 EUR |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human West Nile Virus Envelope . This antibody is tested and proven to work in the following applications: |
|||
West Nile Virus Envelope (WNV E) Antibody |
|||
abx201395-100l | Abbexa | 100 µl | 450 EUR |
West Nile Virus Envelope (WNV E) Antibody |
|||
abx201395-50l | Abbexa | 50 µl | 312.5 EUR |
West Nile Virus Envelope (WNV E) Antibody |
|||
abx201396-100l | Abbexa | 100 µl | 450 EUR |
West Nile Virus Envelope (WNV E) Antibody |
|||
abx201396-50l | Abbexa | 50 µl | 312.5 EUR |
Nile Red (Nile Blue A Oxazone) |
|||
40140064-1 | Glycomatrix | 5 g | 434.29 EUR |
Mouse antibody for West Nile Virus Envelope |
|||
3655 | Virostat | 100 ug | 386.26 EUR |
Description: This is purified Mouse monoclonal antibody against West Nile Virus Envelope for WB, ELISA. |
|||
Mouse antibody for West Nile Virus Envelope |
|||
3661 | Virostat | 100 ug | 386.26 EUR |
Description: This is purified Mouse monoclonal antibody against West Nile Virus Envelope for WB, ELISA. |
|||
Mouse antibody for West Nile Virus Envelope |
|||
3671 | Virostat | 100 ug | 386.26 EUR |
Description: This is purified Mouse monoclonal antibody against West Nile Virus Envelope for WB, ELISA. |
|||
OANB00120-100UG - West Nile Virus NS1 Antibody |
|||
OANB00120-100UG | Aviva Systems Biology | 100ug | 389 EUR |
OANB00120-500UG - West Nile Virus NS1 Antibody |
|||
OANB00120-500UG | Aviva Systems Biology | 500ug | 979 EUR |
OANB00121-100UG - West Nile Virus NS1 Antibody |
|||
OANB00121-100UG | Aviva Systems Biology | 100ug | 389 EUR |
OANB00121-500UG - West Nile Virus NS1 Antibody |
|||
OANB00121-500UG | Aviva Systems Biology | 500ug | 979 EUR |
OAPB00277-100UG - West Nile Virus Core Antibody |
|||
OAPB00277-100UG | Aviva Systems Biology | 0.1mg | 389 EUR |
Mouse Anti-West Nile Virus NS1 Antibody (ID12) |
|||
MAB12159-100 | The Native Antigen Company | 0.1 | 275.56 EUR |
Description: Mouse monoclonal antibody specific for West Nile virus NS1 (clone ID12) |
|||
Mouse Anti-West Nile Virus NS1 Antibody (ID12) |
|||
MAB12159-500 | The Native Antigen Company | 0.5 | 691.46 EUR |
Description: Mouse monoclonal antibody specific for West Nile virus NS1 (clone ID12) |
|||
Mouse Anti-West Nile Virus NS1 Antibody (IC12) |
|||
MAB12160-100 | The Native Antigen Company | 0.1 | 275.56 EUR |
Description: Mouse monoclonal antibody specific for West Nilevirus NS1 (clone IC12) |
|||
Mouse Anti-West Nile Virus NS1 Antibody (IC12) |
|||
MAB12160-500 | The Native Antigen Company | 0.5 | 691.46 EUR |
Description: Mouse monoclonal antibody specific for West Nilevirus NS1 (clone IC12) |
|||
Nile Red |
|||
60029-1 | Biotium | EA | 100 EUR |
Nile Red |
|||
GT2331-1 | Glentham Life Sciences | 1 | 142.4 EUR |